Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × tislelizumab × Clear all

NCT05044871 2025-06-08

BRIGHT

Phase 2 Completed

Ovarian Neoplasms

NCT04815408 2021-03-25

PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer

Phase 2 Unknown

Ovarian Neoplasms